Sort
261,768 grants matching “gene therapy”
Pathogenesis Informs Therapy for Glycosphingolipid and Glycoprotein Disorders
$1,155,231Cynthia Tifft · National Human Genome Research Institute · ZIA · FY2023 · HG
BIOCHEMICAL MARKERS IN THE NURSES'HEALTH STUDY COHORT
$1,155,061Brigham And Women'S Hospital · R01 · FY2001 · CA
Immunobiology of Tolerance FF Allogeneic Hematopoietic Cell Transplantation
$1,155,049John Andrew Hansen · Fred Hutchinson Cancer Research Center · P01 · FY2013 · AI
Translating a CSF delivered AAV9-SMN for treatment of Spinal Muscular Atrophy
$1,155,044Brian K Kaspar · Research Inst Nationwide Children'S Hosp · U01 · FY2014 · NS
Mutational analysis of signal transducing gene families in malignant melanoma
$1,155,041Yardena Samuels · National Human Genome Research Institute · ZIA · FY2009 · HG
Cancer Biology and Genetics
$1,155,009Harold Varmus · National Human Genome Research Institute · ZIA · FY2015 · HG
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
$1,154,998Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2020 · CA
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
$1,154,998Jeffrey Wallace Tyner · Oregon Health & Science University · U54 · FY2021 · CA
Commercialization of cavitation-enhancing nanodroplets for DNA sample fragmentation in NGS applications
$1,154,747Sandeep Kasoji · Triangle Biotechnology, Inc. · R44 · FY2021 · CA
Safety and Efficacy Testing of FX101 in an SIV/NHP Model
$1,154,643Heidi A Kay · Jericho Sciences, Llc · R44 · FY2017 · MH
Center for Neurovisceral Sciences & Women's Health
$1,154,613Emeran A Mayer · University Of California Los Angeles · P50 · FY2010 · DK
QC and Release Testing of Vector and Cell Clinical Gene Therapy Products
$1,154,517Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Identification and use of T-cell receptors recognizing common tumor mutations
$1,154,442James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Histidine phosphorylation as a new target for cancer therapy
$1,154,400Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2020 · CA
Histidine phosphorylation as a new target for cancer therapy
$1,154,400Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2025 · CA
Histidine phosphorylation as a new target for cancer therapy
$1,154,400Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2022 · CA
Autologous T-cells Expressing a Chimeric Antigen Receptor Directed to B-Cell Maturation Antigen (BCMA) in patients with Generalized Myasthenia Gravis (MG)
$1,154,358Metin Kurtoglu · Cartesian Therapeutics, Inc. · R44 · FY2021 · NS
Epigenetic strategies for the in vitro generation of replacement beta cells
$1,154,087Maike Sander · University Of California, San Diego · U01 · FY2013 · DK
Long-Term Neural Determinants of Cardiovascular Diseases
$1,154,053John W Osborn · University Of Minnesota · R01 · FY2009 · HL
Novel 5-HT2A/mGluR5 Antagonist for Opioid Use Disorder
$1,153,945Frederick Gerard Moeller · Virginia Commonwealth University · UG3 · FY2025 · DA
Histidine phosphorylation as a new target for cancer therapy
$1,153,906Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2021 · CA
Center for Narcolepsy and Related Disorders (P50)
$1,153,883Emmanuel J Mignot · Stanford University · P50 · FY2014 · NS
NADPH Oxidases as Novel Targets for Cancer Therapy
$1,153,863James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
The Unfolded Protein Response in Cancer
$1,153,823Constantinos Koumenis · University Of Pennsylvania · P01 · FY2013 · CA
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$1,153,780Clifton Barry · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI